Taxane Benefits in Early Breast Cancer Have Staying PowerTaxane Benefits in Early Breast Cancer Have Staying Power
Long-term clinical trial results support the use of paclitaxel once weekly and docetaxel once every 3 weeks following chemotherapy in women with stage II or III operable breast cancer. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Docetaxel | Health | Hematology | Taxotere | Women